<DOC>
	<DOC>NCT01294969</DOC>
	<brief_summary>To evaluate patient perceptions of Al-4943 in subjects with allergic conjunctivitis previously treated with a topical ocular anti-allergy leukotriene-release inhibitor medication.</brief_summary>
	<brief_title>Patient Perception Study for AL-4943A</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>History of allergic conjunctivitis within last 24 months Active signs and symptoms of ocular allergies Severe or serious ocular condition, ocular surgical intervention, ocular infection</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Allergic conjunctivitis</keyword>
</DOC>